Astaxanthin - Mera
Alternative Names: AstaFactorLatest Information Update: 24 Oct 2021
Price :
$50 *
At a glance
- Originator Mera Pharmaceuticals
- Class Anti-inflammatories; Antineoplastics; Xanthophylls
- Mechanism of Action Antioxidants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cardiovascular disorders; Exercise-induced asthma; Macular degeneration
Most Recent Events
- 20 Sep 2002 Aquasearch is now called Mera Pharmaceuticals
- 11 Jun 2002 No development reported - Clinical-Phase-Unknown for Cardiovascular disorders in USA (PO)
- 11 Jun 2002 No development reported - Clinical-Phase-Unknown for Exercise-induced asthma in USA (PO)